Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Related Citations for PubMed (Select 16405301)

1.

Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.

Scanlan MJ, Ritter G, Yin BW, Williams C Jr, Cohen LS, Coplan KA, Fortunato SR, Frosina D, Lee SY, Murray AE, Chua R, Filonenko VV, Sato E, Old LJ, Jungbluth AA.

Cancer Immun. 2006 Jan 12;6:2.

2.

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.

Zhang S, Zhang HS, Cordon-Cardo C, Ragupathi G, Livingston PO.

Clin Cancer Res. 1998 Nov;4(11):2669-76.

4.
7.

Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.

Chen YT, Hsu M, Lee P, Shin SJ, Mhawech-Fauceglia P, Odunsi K, Altorki NK, Song CJ, Jin BQ, Simpson AJ, Old LJ.

Int J Cancer. 2009 Jun 15;124(12):2893-8. doi: 10.1002/ijc.24296.

PMID:
19296537
8.

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

9.
10.

Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.

Woods AM, Wang WW, Shaw DM, Ward CM, Carroll MW, Rees BR, Stern PL.

Biochem J. 2002 Aug 15;366(Pt 1):353-65.

11.

Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody.

Björk P, Jönsson U, Svedberg H, Larsson K, Lind P, Dillner J, Hedlund G, Dohlsten M, Kalland T.

J Biol Chem. 1993 Nov 15;268(32):24232-41.

12.

Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11.

Chen D, Shou C.

Biochem Biophys Res Commun. 2001 Jan 12;280(1):99-103. Erratum in: Biochem Biophys Res Commun 2001 Mar 16;281(5):1356-7.

PMID:
11162484
13.
14.
15.

Identification of a novel prostate cancer-associated tumor antigen.

Miles AK, Rogers A, Li G, Seth R, Powe D, McArdle SE, McCulloch TA, Bishop MC, Rees RC.

Prostate. 2007 Feb 15;67(3):274-87.

PMID:
17192878
16.

CABYR is a novel cancer-testis antigen in lung cancer.

Luo C, Xiao X, Liu D, Chen S, Li M, Xu A, Liu J, Gao S, Wu S, He D.

Clin Cancer Res. 2007 Feb 15;13(4):1288-97.

17.

The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.

Seil I, Frei C, Sültmann H, Knauer SK, Engels K, Jäger E, Zatloukal K, Pfreundschuh M, Knuth A, Tseng-Chen Y, Jungbluth AA, Stauber RH, Jäger D.

Int J Cancer. 2007 Jun 15;120(12):2635-42.

PMID:
17330232
18.

Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.

Sahin U, Koslowski M, Dhaene K, Usener D, Brandenburg G, Seitz G, Huber C, Türeci O.

Clin Cancer Res. 2008 Dec 1;14(23):7624-34. doi: 10.1158/1078-0432.CCR-08-1547.

19.

A3--a novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells.

Tordsson J, Lavasani S, Ohlsson L, Karlström P, Svedberg H, Abrahmsén L, Brodin T.

Int J Cancer. 2000 Aug 15;87(4):559-68.

PMID:
10918198
20.

WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.

Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, von Knebel Doeberitz M.

Int J Cancer. 2004 Apr 10;109(3):385-92.

PMID:
14961577
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk